Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes. [electronic resource]
Producer: 20210607Description: e13276 p. digitalISSN:- 1399-3062
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunologic Deficiency Syndromes
- Male
- Middle Aged
- Paramyxoviridae Infections -- drug therapy
- Respiratory Syncytial Virus Infections -- drug therapy
- Respiratory Tract Infections -- drug therapy
- Retrospective Studies
- Ribavirin -- therapeutic use
- Risk Factors
- Transplantation, Homologous -- adverse effects
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.